Abstract
Neurosarcoidosis is a diagnostic consideration in diverse clinical settings. Efforts should be made to secure pathologic confirmation of systemic sarcoidosis; only rarely is central nervous system (CNS) pathologic confirmation available. CNS infection and malignancy should be reasonably excluded before making a diagnosis of CNS sarcoidosis. Corticosteroid therapy alone may not be sufficient to treat neurosarcoidosis; adjunct immunosuppressive agents are increasingly used to achieve an optimal clinical outcome.
| Original language | English |
|---|---|
| Pages (from-to) | 185-198 |
| Number of pages | 14 |
| Journal | Neurologic Clinics |
| Volume | 28 |
| Issue number | 1 |
| DOIs | |
| State | Published - Feb 2010 |
Keywords
- Diagnosis
- Immunosuppression
- Neurology
- Sarcoidosis